Literature DB >> 27366520

Effect of Ketamine, Thiopental and Ketamine-Thiopental Combination during Electroconvulsive Therapy for Depression.

Özlem Özkan Kuşçu1, Feride Karacaer2, Ebru Biricik2, Ersel Güleç2, Lut Tamam3, Yasemin Güneş2.   

Abstract

OBJECTIVE: We aimed to evaluate the effect of anaesthesia with thiopental (4 mg kg(-1)), ketamine (1 mg kg(-1)) and ketamine-thiopental (1 mg kg(-1) and 4 mg kg(-1), respectively) combination during electroconvulsive therapy (ECT) on the Hamilton Depression Rating Scale (HDRS) and Hamilton Anxiety Rating Scale (HAM-A) and haemodynamic variables in patients with resistant major depression.
METHODS: Patients with HDRS scores above 17 were included. The patients were randomly divided into three groups according to the anaesthesia used. Group 1 was given thiopental (4 mg kg(-1)), Group 2 was given ketamine (1 mg kg(-1)) and Group 3 was given ketamine (1 mg kg(-1)) and thiopental (4 mg kg(-1)). Succinylcholine (1 mg kg(-1)) was administered in all patients for muscle relaxation. HDRS and HAM-A scores were evaluated before ECT, after 3, 6. ECT and after the final ECT. Systolic and diastolic blood pressures, heart rates and oxygen saturations were recorded before and after anaesthesia induction and after the ECT procedure. Seizure duration was recorded.
RESULTS: Fifty-eight patients were included in the study. Thirty (52%) patients were male and 28 (48%) were female. The mean age was 42.7±15.8 years in Group 1, 44.8±11 years in Group 2 and 38.6±6.8 years in Group 3. In all groups, HDRS scores were reduced compared with the baseline values. There was no statistical significant difference between the groups regarding HDRS scores. HAM-A scores were higher in Group 2 and Group 3. Systolic and diastolic blood pressures and heart rate values were lower in Group 1 and the difference was statistically significant.
CONCLUSION: In this study, anaesthesia induced with thiopental, ketamine and thiopental-ketamine combination was observed to not result in a difference in ECT for patients with treatment-resistant depression. Ketamine at a dose of 1 mg kg(-1) given just before ECT did not enhance the antidepressant effect of ECT; however, anxiety scores were increased with ketamine application.

Entities:  

Keywords:  Depression; anxiety; electroconvulsive therapy; ketamine; thiopental

Year:  2015        PMID: 27366520      PMCID: PMC4894231          DOI: 10.5152/TJAR.2015.92668

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  23 in total

Review 1.  Electroconvulsive therapy: a review of the literature.

Authors:  V Challiner; L Griffiths
Journal:  J Psychiatr Ment Health Nurs       Date:  2000-06       Impact factor: 2.952

Review 2.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

3.  Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.

Authors:  Marianne H Larsen; Jens D Mikkelsen; Anders Hay-Schmidt; Carmen Sandi
Journal:  J Psychiatr Res       Date:  2010-02-20       Impact factor: 4.791

4.  Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder.

Authors:  Xiaobin Wang; Yunliang Chen; Xian Zhou; Fenghua Liu; Tao Zhang; Chunxiang Zhang
Journal:  J ECT       Date:  2012-06       Impact factor: 3.635

5.  Failed response to repeat intravenous ketamine infusions in geriatric patients with major depressive disorder.

Authors:  Sarah M Szymkowicz; Nora Finnegan; Roman M Dale
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

6.  Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia.

Authors:  Nagahisa Okamoto; Tetsuji Nakai; Kota Sakamoto; Yuko Nagafusa; Teruhiko Higuchi; Toru Nishikawa
Journal:  J ECT       Date:  2010-09       Impact factor: 3.635

Review 7.  Ketamine.

Authors:  B Sinner; B M Graf
Journal:  Handb Exp Pharmacol       Date:  2008

8.  The drugs don't work? antidepressants and the current and future pharmacological management of depression.

Authors:  Elizabeth Penn; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2012-10

9.  Small-dose ketamine improves the postoperative state of depressed patients.

Authors:  Akira Kudoh; Yoko Takahira; Hiroshi Katagai; Tomoko Takazawa
Journal:  Anesth Analg       Date:  2002-07       Impact factor: 5.108

Review 10.  Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy.

Authors:  Caroline Caddy; Giovanni Giaroli; Thomas P White; Sukhwinder S Shergill; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2014-04
View more
  7 in total

Review 1.  Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.

Authors:  Marc S Lener; Bashkim Kadriu; Carlos A Zarate
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 2.  Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.

Authors:  Rebecca L Dean; Claudia Hurducas; Keith Hawton; Styliani Spyridi; Philip J Cowen; Sarah Hollingsworth; Tahnee Marquardt; Annabelle Barnes; Rebecca Smith; Rupert McShane; Erick H Turner; Andrea Cipriani
Journal:  Cochrane Database Syst Rev       Date:  2021-09-12

3.  Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.

Authors:  Ian M Anderson; Andrew Blamire; Tim Branton; Ross Clark; Darragh Downey; Graham Dunn; Andrew Easton; Rebecca Elliott; Clare Elwell; Katherine Hayden; Fiona Holland; Salman Karim; Colleen Loo; Jo Lowe; Rajesh Nair; Timothy Oakley; Antony Prakash; Parveen K Sharma; Stephen R Williams; R Hamish McAllister-Williams
Journal:  Lancet Psychiatry       Date:  2017-03-27       Impact factor: 27.083

Review 4.  A review of ketamine's role in ECT and non-ECT settings.

Authors:  Vytautas Jankauskas; Candace Necyk; James Chue; Pierre Chue
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-06       Impact factor: 2.570

Review 5.  Ketamine and depression: a narrative review.

Authors:  Alexandrine Corriger; Gisèle Pickering
Journal:  Drug Des Devel Ther       Date:  2019-08-27       Impact factor: 4.162

6.  Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials.

Authors:  Xiao-Mei Li; Zhan-Ming Shi; Pei-Jia Wang; Hua Hu
Journal:  Gen Psychiatr       Date:  2020-06-16

7.  Dexmedetomidine Regulates the miR-146a-5p/NF-κB Axis to Alleviate Electroconvulsive Therapy-Induced Cognitive Impairments.

Authors:  Xiaohui Zhou; Peipei Si; Li Wang; Huiqun Jia
Journal:  Comput Math Methods Med       Date:  2022-10-04       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.